CCIA
AGIO icon

Campbell & Co Investment Adviser’s Agios Pharmaceuticals AGIO Stock Holding History

Campbell & Co Investment Adviser’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71M Buy
+73,095
New +$2.22M 0.14% 227
2026
Q1 		– Sell
-8,226
Closed -$224K – 1030
2025
Q4 		$224K Buy
+8,226
New +$289K 0.01% 1038
2024
Q1 		– Sell
-42,686
Closed -$951K – 1078
2023
Q4 		$951K Buy
+42,686
New +$957K 0.09% 409
2022
Q3 		– Sell
-16,564
Closed -$367K – 693
2022
Q2 		$367K Buy
+16,564
New +$374K 0.1% 386

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Campbell & Co Investment Adviser's AGIO Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 73,095 shares worth $2.71M. The stake represents 0.14% of the portfolio and ranks #227 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in AGIO as recently as Q4 2025.

Campbell & Co Investment Adviser first reported a position in AGIO in Q2 2022 and has held it in 4 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Campbell & Co Investment Adviser held 73,095 shares of Agios Pharmaceuticals worth $2.71M as of Q2 2026.
  • Agios Pharmaceuticals was a new Campbell & Co Investment Adviser position in Q2 2026.
  • Agios Pharmaceuticals made up 0.14% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #227 holding.
  • Campbell & Co Investment Adviser first reported a position in Agios Pharmaceuticals in Q2 2022 and has held it in 4 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.